Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why GSK Plc And Sanofi SA Stock Are Shooting Higher

Shares of GSK plc (NYSE: GSK) and Sanofi SA (NASDAQ: SNY) are trading higher going into the close of Tuesday's session after the companies reportedly won a Zantac product liability lawsuit.
byHenry Khederian
December 6, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Shares of GSK plc (NYSE:GSK) and Sanofi SA (NASDAQ:SNY) are trading higher going into the close of Tuesday’s session after the companies reportedly won a Zantac product liability lawsuit.

The drugmakers on Tuesday defeated thousands of lawsuits in U.S. federal court, per a court filing. The lawsuits claimed that the popular heartburn drug Zantac caused cancer. A judge found the claims were not backed by sound science.

According to data from Benzinga Pro:

  • GSK closed higher by 7.85% to $37.92
  • SNY closed higher by 8.06% to $48.55

 

 

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Chevron’s Wild Week: Charting The Stock’s Ride On Dividend, Buyback News — And Q4 Earnings Miss

By Joel Elconin
January 27, 5:45 PM
If a company offers up some good news the day ahead of an earnings announcement, it has to seem a bit fishy. In other words, why not wait until the following day to alert investors of the planned announcement (earnings) and the other unknown news? Unless, of course, the company is anticipating a negative reaction to the earnings report.

CVX